Company data
BridgeBio Pharma, Inc. employees and revenue per employee
BBIO · Biotechnology · $13.2B market cap
BridgeBio Pharma, Inc. had 834 employees at the end of fiscal Dec 2025, up 15.0% from a year earlier. Revenue for the year was $502M, up 126.3% from a year earlier, or $602K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
834
+15.0% YoY
Revenue
$502M
+126.3% YoY
Revenue / employee
$602K
Peer median $602K
Rank in industry
20 of 39
Biotechnology
Open roles
66
79 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 834 | $502M | $602K | +15.0% | +126.3% |
| Dec 2024 | 725 | $222M | $306K | +31.8% | +2285.3% |
| Dec 2023 | 550 | $9.3M | $17K | +40.3% | -88.0% |
| Dec 2022 | 392 | $77.6M | $198K | -31.9% | +11.4% |
| Dec 2021 | 576 | $69.7M | $121K | +49.6% | +745.1% |
| Dec 2020 | 385 | $8.2M | $21K | +55.2% | -79.7% |
| Dec 2019 | 248 | $40.6M | $164K | — | — |
Open roles on its job board: 66 (79 per 1,000 staff, against its latest annual headcount), as of 2026-10-07. Tracked since 2026-10-03. No 90 day change yet.
BridgeBio Pharma, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| KRYS Krystal Biotech, Inc. | 295 | $389M | $1.32M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| ADMA ADMA Biologics, Inc. | 647 | $510M | $789K | Leaner |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| BBIO BridgeBio Pharma, Inc. | 834 | $502M | $602K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| TWST Twist Bioscience Corporation | 979 | $377M | $385K | Efficient growth |
| INSM Insmed Incorporated | 1,664 | $606M | $364K | Efficient growth |
Questions about BridgeBio Pharma, Inc.
- How many employees does BridgeBio Pharma, Inc. have?
- BridgeBio Pharma, Inc. reported 834 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is up 15.0% from a year earlier.
- What is BridgeBio Pharma, Inc.'s revenue per employee?
- BridgeBio Pharma, Inc. brought in $502M of revenue in fiscal Dec 2025, which is $602K per employee. That ranks 20 of 39 companies we track in Biotechnology, where the median is $602K.
- Is BridgeBio Pharma, Inc. hiring?
- BridgeBio Pharma, Inc.'s public job board listed 66 open roles on October 7, 2026, about 79 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare BBIO with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in BridgeBio Pharma, Inc.'s annual reports (Form 10-K), latest filed February 24, 2026. This is data, not a recommendation to buy or sell BBIO.